The Myomo technology was originally developed at Massachusetts Institute of Technology (MIT) in collaboration with medical experts affiliated with Harvard Medical School. In 2006, the Company was spun out from MIT and became the exclusive licensee of two patents behind the myoelectric technology.
Myomo's first device, the e100 System, was approved by the U.S. Food and Drug Administration (FDA) in July 2007 as a Class II device, which allowed it to be sold to and used in hospitals and rehabilitation facilities to facilitate therapy. The product was named one of Popular Science's "Best of What's New" in the personal health category for 2007.
In 2012, Myomo introduced the mPower 1000 myoelectric system. The new device
came in a universal-size with detachable sensors and was designed for rehabilitation
and therapy centers.
In April 2012, Myomo introduced the third generation of its technology, the MyoPro
custom fit orthosis, which is custom molded to each patient and designed for home use
to facilitate functional tasks and patient independence